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Imaging of Pediatric Benign Bone
Tumors
Jignesh Shah and Ankita Chauhan
Abstract
Benign bone tumors in the pediatric population can have varied clinical
presentations ranging from asymptomatic to nonspecific pain, swelling, or patho-
logical fracture. A systemic imaging approach should be utilized to evaluate for
focal bone abnormalities. Radiologists must be aware of salient imaging features of
pediatric benign bone tumors, as it helps to guide clinicians for further management
and help decreasing patient anxiety and unnecessary medical intervention.
Keywords: Pediatric benign bone tumors, Osteoid Osteoma, Enchondroma,
Non-Ossifying Fibroma
1. Introduction
Primary benign bone tumors are more common than malignancies in children.
The patient’s age and lesion location are two critical factors when evaluating for a
bone tumor. The initial imaging modality to evaluate for a bone tumor is radiogra-
phy. Radiographs confirm the presence and location of a tumor, assist in the for-
mulation of differential diagnosis, characterize the tumor, and guide in selecting
further imaging. Cross-sectional imaging is helpful for tissue characterization and
for evaluating the extent of the lesions. The patient’s age helps to narrow down the
differential diagnosis.
2. Classification




















The location of the lesion in the bone can help narrow down the differential
diagnosis.



















Some lesions are solitary, and others are multifocal at presentation. The
following are the examples of multifocal pediatric benign bone lesions:
Brown tumors (hyperparathyroidism).
Cystic angiomatosis/lymphangiomatosis.
Enchondroma (Ollier disease, Maffucci syndrome).
Fibrous dysplasia (McCune-Albright syndrome).
Infiltrate myofibromatosis.
Langerhans cell histiocytosis.
Nonossifying fibroma (Jaffe-Campanacci Syndrome).
Osteochondroma (Diaphyseal Aclasis).
Chronic recurrent multifocal osteomyelitis (CRMO).
The following features are characteristic for nonaggressive benign bone lesions
and help differentiate from aggressive malignant bone lesions:
Well-defined margins with a narrow zone of transition.
Expansion of bone from slow growth.
Smooth periosteal new bone formation.
Absence of an associated soft tissue mass.
Some benign bone tumors are adequately defined by radiographs and do not
require any further imaging for diagnosis or treatment. However, most bone tumors
require additional imaging; this may be in the form of CT, MRI, scintigraphy, PET
scanning, and rarely ultrasound. The choice of imaging for a given tumor depends
on the differential diagnostic considerations, possible treatment options, and
whether the lesion is aggressive or nonaggressive.
Classification of pediatric bone tumors according to matrix or tissue type:
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Cystic lesions: Unicameral (simple) bone cyst, aneurysmal bone cyst.
Osteoid matrix lesions: Enostosis, osteoma, osteoid osteoma, osteoblastoma.
Chondroid matrix: Enchondroma, chondroblastoma, chondromyxoid fibroma,
osteochondroma, juxtacortical chondroma.
Fibro-osseous lesions: Nonossifying fibroma, fibrous dysplasia, osteofibrous
dysplasia.
Fat containing lesions: Lipoma.
Vascular malformations: Hemangioma.
Giant cell tumors: Giant cell tumor.
Others: Langerhans cell histiocytosis.
3. Primary benign bone tumors by tissue type
Cystic bone lesions:
1.Simple bone cyst:
A simple bone cyst is also called a solitary cyst or unicameral bone cyst (UBC).
A simple bone cyst is a common benign nonneoplastic lucent bony lesion
mainly seen in childhood and typically asymptomatic. Approximately 85% of
unicameral bone cysts occur in children and adolescents [1]. There is 2–3:1
male predominance [2]. During the active phase, the cyst increases in size and
remains close to the physis. The latent phase cysts are found farther from the
physis and usually do not continue to grow. Cysts may appear to migrate into
diaphysis, but actually, it is the growth plate that migrates away from the cyst.
The lesions are usually asymptomatic and found incidentally, although the
adjacent joint’s pain, swelling, and stiffness can also occur. The most frequent
complication is a pathologic fracture, and this is usually the cause of
presentation. 75% of patients come in with a pathologic fracture [3].
Pathologically, the cysts contain clear serosanguineous fluid surrounded by
fibrous membranous lining. The proximal humerus is the most common
location (in 50–60% of cases) [4]. The second most common location is the
proximal femur.
On radiography, bone cysts are located centrally in the medullary cavity
within the metaphysis. Most cysts are less than 3 cm in short-axis diameter but
may be much larger in the long axis. The cyst wall is well-defined and
sclerotic; the overlying cortex is thinned, and the lesion may be mildly
expansile (Figures 1A, 2A). Following a fracture, a fragment of bone may be
seen dependently within the cyst, called a fallen fragment sign, considered
pathognomonic for a simple bone cyst [5] (Figure 3A).
Computed Tomography (CT) scan and Magnetic Resonance Imaging (MRI)
can help exclude other entities that can potentially mimic a simple bone cyst
such as an intraosseous lipoma, fibrous dysplasia, eosinophilic granuloma,
giant cell tumor, nonossifying fibroma, or aneurysmal bone cyst. The CT scan
helps to delineate the cyst and confirms a fallen fragment. MRI confirms the
cystic nature of the lesion. The fluid contents are low signal on T1 and high
signal on T2-weighted imaging (Figure 1B and C). In contrast, the cyst lining
enhances, but the contents do not (Figures 1D, 2C). Occasionally, when
presenting with intralesional hemorrhage from fracture, fluid–fluid levels may
be seen representing internal degraded blood products. The internal
hemorrhage may evolve into septations that can be demonstrated on MRI
(Figure 2B).
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On scintigraphy, the unicameral bone cyst appears as a focus of photopenia
(cold spot). It may have increased uptake peripherally, and a photopenic
center sometimes referred to as a doughnut sign. However, a pathologic
fracture would cause an increased radioisotope activity.
Figure 2.
Simple Bone Cyst: Frontal radiograph of the right humerus (A) demonstrates an expansile circumscribed lytic
lesion (white arrow) in the proximal diaphysis with a narrow zone of transition. It has scalloped margins,
suggesting chronicity. No cortical breach is demonstrated. Coronal T2-weighted fat-saturated MR image (B)
reveals heterogeneous hyperintense signal of the simple bone cyst (white arrow) with a few thin linear T2-
hypointensities (septations; black arrow) within. The bone cyst (white arrow) demonstrates peripheral rim
enhancement on the post-contrast T1-weighted fat-saturated image (C).
Figure 1.
Simple Bone Cyst: Frontal radiograph of the right femur demonstrates a well-circumscribed, lytic, proximal
metadiaphyseal lesion (white arrow) with a narrow zone of transition and represents a simple bone cyst (A).
There is no fracture. On the coronal MR sequences (B–D), the simple bone cyst (white arrows) shows an
intermediate signal on T1-weighted sequence (B), a homogeneous increased signal on T2-weighted imaging (C),
and peripheral rim enhancement on the post-contrast T1-weighted fat-saturated imaging (D). A simple bone
cyst is treated by bone grafting. Fluoroscopic spot image of the right femur (E) confirms that the osteolytic lesion
is cemented by the bone graft material (white asterisk).
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The larger cysts with or without fracture are usually treated with curettage
and bone grafting [6] (Figures 1E, 3B). The fractured cyst tends to heal
spontaneously. The prognosis is excellent, although 25% of bone cysts recur
after curettage [7]. Cyst aspiration with corticosteroid injection or
sclerotherapy has also been used for treatment. Intervention is usually not
required for an asymptomatic lesion.
2.Aneurysmal bone cyst:
An aneurysmal bone cyst is a benign, radiolucent, expansile, and hemorrhagic
lesion of uncertain etiology. Pathologically, the lesion comprises numerous
blood-filled nonendothelialized channels separated by connective tissue of
bone or osteoid tissue and osteoclastic giant cells. Aneurysmal bone cyst
affects 0.14 per 1,00,000 of the population [8]. There may be a slight female
predominance. 75–90% of cases occurred before the age of 20 [9]. The patient
usually presents with nonspecific pain and swelling, and a minority of patients
(approximately 10%) present with pathological fractures. The lesions are most
commonly located in the metaphysis of long bones, the craniofacial bones, and
the spine; spinal lesions occur in the posterior elements.
The aneurysmal bone cysts are sharply defined on radiographs and appear as
expansile osteolytic lesions with thin sclerotic margins, frequently termed a
soap bubble lesion [10] (Figures 4A, 5A). If the lesion is wider than the
affected normal bone, an ABC should be considered. ABCs are typically
multiloculated, and the cortex is usually intact but maybe markedly thinned to
the point of being invisible, and the periosteal new bone may be present. CT
scan demonstrates these findings better and accurately assesses cortical breach
and extension to the soft tissues (Figure 5C). Additionally, the CT and MRI
demonstrate fluid–fluid levels, which are characteristic of the lesion
(Figures 4C, 5B). Fluid–fluid levels are due to the dependent location of
degraded blood products, especially methemoglobin, which has a much
shorter T1 relaxation time than hemoglobin. Fluid–fluid levels may be single
Figure 3.
Simple Bone Cyst: Frontal radiograph of the right femur (A) demonstrates a pathological fracture (thick
arrows) through a circumscribed expansile lytic proximal meta-diaphyseal lesion (white arrow). It represents a
simple bone cyst with the characteristic fallen-fragment sign (yellow arrow). A follow-up post-treatment
frontal radiograph of the right femur (B) shows graft material (white asterisk) cementing the bone cyst and a
transfixed healing fracture with good periosteal reaction (black arrow).
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Figure 4.
Aneurysmal Bone Cyst: Lateral radiograph of the left tibia (A) shows a well-circumscribed, expansile, lytic
lesion (white arrow) involving the proximal tibial metadiaphysis. It demonstrates internal heterogeneity and
has a narrow zone of transition. Coronal T1-weighted image (B) reveals the multiloculated appearance of the
lesion (white arrow) and a predominantly intermediate T1 signal. No associated soft tissue swelling is noted.
Sagittal fat-saturated T2-weighted image (C) shows multiple fluid-fluid levels within the lesion (yellow
arrows), a characteristic imaging feature of an aneurysmal bone cyst.
Figure 5.
Aneurysmal Bone Cyst: Lateral radiograph of the pelvis (A) shows an expansile, circumscribed, lytic, proximal
femoral metaphyseal lesion (white arrow) with scalloped margins. On axial fat-saturated T2-weighted
imaging (B), the lesion shows multiple fluid-fluid levels within (yellow arrow), suggesting an aneurysmal bone
cyst. C and D are images of an aneurysmal bone cyst in the left pubic bone in a different patient. The
aneurysmal bone cyst appears as a well-circumscribed lytic lesion on CT (C). Coronal T1-weighted fat-
saturated post-contrast image (D) depicts heterogeneous and peripheral enhancement of the aneurysmal bone
cyst.
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or multiple and may be seen as varying horizontal levels within the separate
loculations [11]. The signal characteristics of the cyst contents depend on the
relative age and concentration of blood components. Abundant hemosiderin
may produce areas of low signal. On T1, the cyst is predominantly
hypointense (Figure 4B). Cyst contents do not enhance, but the septations
and wall do (Figure 5D).
It may not be possible to differentiate primary and secondary ABCs.
Approximately 30% ABC’s are secondary [12]. According to one study, the
most common reasons for secondary ABC are chondroblastoma and giant cell
tumor [13]. Secondary ABC can also be found in other lesions such as
osteoblastoma, chondromyxoid fibroma, fibrous dysplasia, and nonossifying
fibroma.
Treatment: Most ABCs are treated with curettage and bone grafting.
Recurrence rate is approximately 12–30% after initial treatment [14].
Percutaneous treatment with fibrosing agents has also been performed, either
in isolation or as a precursor to surgical excision. According to one institution’s
experience, many ABCs can be treated with polidocanol sclerotherapy [15].
Vascular embolization has also been used. MRI is helpful to identify any solid
components which can guide the surgeon for biopsy.
Bone lesions containing osteoid matrix:
1.Enostosis:
Enostosis, also known as the bone island, is a benign focus of compact
(cortical) bone located within the cancellous bone (medullary cavity). The
bone island is most commonly found incidentally. Pathologically, a bone
island is a normal cortical bone containing Haversian canals. There are
radiations of cortical bone blending into the normal cancellous bone at the
periphery of the lesion. The bone island is likely developmental, a normal
cortical bone that fails to resolve during the growth process of endochondral
ossification. The bone island is seen in adults far more frequently than
children. There is no gender predilection. The bone island is generally a
radiographic diagnosis. The bone island is a homogeneously dense lesion on
radiography, fading at the periphery and merging into normal marrow. The
periphery of the bone island is described as brush-like; may appear somewhat
stellate [16] (Figure 6A). There is no associated cortical destruction.
Polyostotic bone islands concentrated in the metaphyseal region are termed
Figure 6.
Enostosis: Frontal radiograph of left humerus (A) shows a circumscribed focal sclerosis (white arrow) in the
proximal epiphysis with peripheral brush border extensions into the normal adjacent bone. Axial T1-weighted
(B) and T2-weighted fat-saturated (C) images reveal marked hypointense signal of the bone island.
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osteopoikilosis. Multiple sclerotic bone lesions can also be seen in patients
with tuberous sclerosis complex [17].
On CT scan, enostosis is a sclerotic lesion with peripheral brush border
extensions into the normal adjacent bone. Enostosis generally has a mean CT
attenuation above 885 Hounsfield units (HU), whereas untreated osteoblastic
metastases have mean CT attenuation below 885 HU, according to one study
[18]. On MRI, the enostosis demonstrates low signal on all sequences with
characteristic peripheral brush border extension into the normal bone
(Figure 6B andC). There is no postcontrast enhancement. On nuclear medicine
scintigraphy, if the lesion size is more than 1 cm, increased radiotracer uptake is
related to the osteoblastic activity. SPECT CT has a sensitivity of up to 90% in
detecting sclerotic bone metastases [19]. No treatment is required for enostosis.
2.Osteoma:
Osteoma is a benign tumor that demonstrates well-differentiated bone
formation without aggressive features. Synonyms of osteoma include surface
osteoma, parosteal osteoma, ivory osteoma, Ivory exostosis, and hamartoma
of bone. Pathologically, osteoma is a hard white dense cortical bone. Many
osteomas demonstrate a mixture of bone types. Osteomas may contain
cancellous (trabecular, spongy) regions with a thin trabecular architecture
with fatty marrow; woven bone with a fairly mature matrix with prominent
collagen fibers; and lamellar (compact regions), which have narrow parallel
layers of mature bone matrix. Most commonly, osteomas are found
incidentally, with less than 5% of osteomas are symptomatic. The symptoms
may be related to the mass effect upon the adjacent soft tissue structures,
including proptosis, diplopia, sinusitis, mucocele, abscess as a complication of
sinus blockage. Osteoma affects all age groups, including children, although
most commonly diagnosed in the fourth and fifth decades of life [20]. The
male to female ratio is 2:1. More than 75% of osteomas are seen in paranasal
sinuses. The most common paranasal sinus affected is the frontal sinus (80%
cases) [21]. Gardner syndrome has a known association with osteoma.
Gardner syndrome is an autosomal dominant condition in which the patient
may also have multiple cutaneous and subcutaneous lesions (cyst, fibromas),
desmoid tumors, and multiple colonic polyps (colonic polyps in Gardner’s
syndrome have a marked propensity to develop adenocarcinoma).
In radiography and CT scan, the osteoma is seen as a homogeneous bone
density lesion due to well-differentiated lamellar bone formation. The borders
of osteomas are sharply demarcated (Figure 7A–D). There is no periosteal
reaction. On MRI, osteomas are seen as low signal intensity on all sequences,
without enhancement. Enhanced MRI or CT scan is best to evaluate
complications such as mucocele, pneumatocele, or abscess. Treatment is
required if intracranial or intraorbital extension, location near frontal sinus
ostium, more than 50% of the frontal sinus filled by osteoma or unrelenting
symptoms [22]. The endoscopic approach for resection is effective in low-
grade osteomas. In particular, the open approach, the osteoplastic flap
approach, is well tolerated for resection of higher grade osteomas [23].
3.Osteoid Osteoma:
Osteoid osteoma is a benign tumor of osteoblastic origin. The osteoid osteoma
is often called “nidus” to distinguish it from surrounding reactive sclerosis
from host response. There may be a genetic basis in chromosome band 22q13
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in the patients with osteoid osteoma [24]. The osteoid osteoma contains a
central region of vascularized connective tissue that contains osteoblasts and
microtrabecular arrays lined by plump appositional osteoblasts. Around the
central region, there is a hypervascular sclerotic bone and an abrupt interface
between the central lesion and surrounding sclerosis. Osteoid osteoma is
relatively common, comprising 5% of all bone tumors and 11% of all benign
bone tumors [25]. The most common age range is 10–25 years with a male
predilection (Male: female is 3:1) [26]. The classic clinical presentation
includes pain, which worsens at night and is relieved by nonsteroidal anti-
inflammatory drugs. There is a gradual worsening of the pain over time.
Intracapsular lesions may present with signs of synovitis, joint pain, and
decreased range of motion. The spinal osteoid osteoma may present with
painful nonrotatory scoliosis and concave to the lesion’s side [27]. The most
common location is cortical diaphyseal, in 65–70% of cases. The most common
site involved is femur and tibia, which collectively account for 60% of osteoid
osteomas [28]. The nidus is generally less than 2 cm in size.
On radiography, osteoid osteoma appears as an oval lytic lesion located within
the dense cortical bone surrounding thickened sclerotic cortical bone
(Figure 8A and B). CT scan helps diagnose and specify the lesion’s location
(whether cortical versus subperiosteal or medullary) (Figure 8C and D). CT
scan is also helpful to guide percutaneous radiofrequency ablation or
cryoablation. The nidus is a round lesion on MRI, slightly hyperintense to
muscle on T1-weighted images and hyperintense on T2-weighted images.
There is avid arterial phase enhancement of the nidus following contrast
administration (Figure 8E). The surrounding cortical thickening and reaction
is low signal intensity on all sequences. In nuclear medicine scintigraphy, the
Figure 7.
Osteoma: Sagittal image (bone algorithm, A) and coronal image (bone window, B) of the paranasal sinuses
reveal a compact and trabecular sclerotic polypoidal osteoma (black arrows) in the left ethmoid and sphenoid
sinuses, extending into the left maxillary sinus with associated occlusion of left osteomeatal unit and left
maxillary sinusitis (asterisk). Osteoma can also present as a less dense mass, as depicted by the rounded
heterogeneous dense mass in the left posterior ethmoid sinus on the axial CT image (C). Note the high Hounsfield
unit of the osteoma (D).
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osteoid osteoma demonstrates intense round activity at the nidus, surrounded
by less intensity of reactive bone, often termed as double density sign [29].
The round focus can help distinguish from a stress reaction, which has more
linear activity. CT-guided radiofrequency ablation is most likely used to treat
osteoid osteomas with an 85–90% initial success rate [30]. Larger or
nonspherical lesions may require a second ablative procedure. The CT-guided
ablation requires careful planning of an approach to avoid complications.
Other alternatives include MR-guided laser ablation or ultrasound ablation.
4.Osteoblastoma:
Osteoblastoma is a rare benign bone-forming tumor, also known as giant
osteoid osteoma. Pathologically, osteoblastoma contains elements of osteoid
production in the form of active formation of osteoid and immature bone
trabeculae. Aggressive osteoblastoma is characterized by epithelioid
Figure 8.
Osteoid Osteoma: Frontal radiograph of the right femur (A) demonstrates an eccentric lucent area along the
medial femoral neck cortex (black arrow) with marginal sclerosis (white arrow). Lateral radiographic view of
the calcaneus (B) showing similar lesion with a central lucency surrounded by extensive sclerosis. Axial CT
image on the same patient confirms the eccentric location of the lucency that shows an eccentric hyperdense focal
speck within, suggesting nidus (C). Osteoid osteoma of the fibula in a different patient appears as a cortical-
based lucency with nidus within (black arrow) on axial CT image (D). Axial post-contrast T1-weighted fat-
saturated image (E) of the leg at the same level demonstrates enhancement of nidus (black arrow) and adjacent
soft tissue.
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osteoblasts, which are significantly larger than normal osteoblasts. Histologic
differentiation between osteoblastoma and osteoid osteoma may be difficult.
The most commonly affected age group is 1st through third decades, with the
second decade being the most common [31]. Male:Female ratio is 2.5:1 [32].
The most common presenting symptom is dull, localized, gradually increasing
pain. The patient may present with neurologic symptoms if cord or nerve root
compression is reported in approximately 50% of spinal lesions [33].
Approximately 30–40% of osteoblastoma occurs in the spine or flat bones
[34]. In the spine, posterior elements are most frequently affected (in 94% of
cases). The osteoblastoma is usually expanded on imaging, maybe bubbly with
a thin cortex and variable degrees of mineralized matrix. There may be a
sclerotic margin in the majority of the cases. Matrix ossification and thin
cortical rim are more apparent on CT scan than x-ray (Figure 9A–C).
On MRI, osteoblastoma is homogeneous low to intermediate signal on T1-
weighted images and heterogeneous on fluid sensitive sequences depending
on the degree of matrix ossification (Figure 9D and E). The enhancement
ranges from mild to intense depending on the amount of matrix ossification.
There may be associated extensive peripheral marrow edema and associated
soft tissue edema due to the flare phenomenon [35] (Figure 10A–C). On
nuclear medicine scintigraphy, osteoblastoma demonstrates intense focal
Figure 9.
Osteoblastoma: CT Head axial (A, B) and coronal (C) images in the bone window reveal a circumscribed,
expansile, heterogeneous mixed lytic and sclerotic lesion (white arrows) involving the mastoid part of the left
temporal bone and has an extradural intracranial component superiorly. Coronal T2-weighted image (D) of
the brain at the level of mass (white arrows) reveals heterogenous increased T2 signal of the well-circumscribed
mass. Osteoblastoma (white arrow) shows an iso-to-hypointense T1 signal (E).
Figure 10.
Osteoblastoma: Axial MR images of the lumbar spine shows an expansile mass lesion involving the left lamina
and pedicle, encroaching in the spinal canal. It demonstrates heterogeneous hyperintense T2 signal (white
arrow) with subtle fluid-fluid levels (A). The lesion shows an intermediate T1 signal (B) and shows
heterogeneous enhancement as depicted in the T1-weighted post-contrast (C). The left posterior paraspinal
muscles demonstrate hyperintense T2 signal and post-contrast enhancement (black asterisks).
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uptake. Surgical excision, in particular, marginal excision (curettage), is most
recommended if wide resection would results in functional impairment.
Incomplete excision may result in recurrence (14–24% reported in different
series) [36, 37]. Other treatment options include percutaneous thermal
ablation. Sporadic cases of osteoblastoma degenerating to osteosarcoma have
been reported [38].
Cartilage forming tumors:
1.Enchondroma: Enchondroma is a benign tumor of hyaline cartilage
originating in the medullary bone. Enchondromas arise from growth plate
cartilage rests and/or chondrocytes that subsequently proliferate and slowly
enlarge and are composed of mature hyaline cartilage. The most common
location of enchondroma is the medullary cavity of tubular bones.
Enchondroma accounts for 12–24% of all benign bone tumors and 3–10% of all
bone tumors [39, 40]. Approximately 35% of enchondromas occur in hands
[40]. In long bones, the proximal humerus is the most common location.
Enchondromas are usually detected incidentally on x-ray or MRI. The majority
of enchondromas are detected in the third through fifth decades of life [41].
There is no gender predilection. Enchondroma is the most common tumor of
the phalanges of the hand. The classic radiographic appearance of
enchondroma in the long bones is a metaphyseal lesion with ring and arc type
of chondroid mineralization without endosteal scalloping, cortical destruction,
or soft tissue mass (Figure 11A and B). In phalanges, the enchondroma
demonstrates an expansile lucent lesion with cortical thinning (Figure 11D and E).
The phalangeal enchondroma may present with pathologic fracture. On MRI,
the enchondroma demonstrates low to intermediate signal intensity on T1-
weighted images and lobulated high signal on fluid sensitive sequences.
Dynamic contrast-enhanced MRI may improve chances of differentiating
enchondroma from low-grade chondrosarcoma [42]. Treatment is usually not
required for small incidental lesions. For large symptomatic lesions, marginal
and/or wide resection should be considered. Sarcoma follow-up surveillance is
required if histologic findings showed low-grade chondrosarcoma.
Ollier disease is a nonhereditary, sporadic skeletal disorder characterized by
multiple enchondromas principally located in the metaphyseal regions. If
there are associated soft tissue hemangiomas, the syndrome is termed
Maffucci syndrome [43]. In Ollier disease, the enchondromas demonstrate
vertical streaks of lucencies in the columnar configuration, in metaphases of
long bones, extending to the epiphysis [43] (Figure 12B and C). The
phalangeal lesions are typically expansile with sharply defined scalloped
margins (Figure 12A). There is an approximately 25–30% risk of
chondrosarcoma in the setting of Ollier disease [44]. Corrective surgery is
required if there are complications such as growth impairment, deformity
such as leg length discrepancy.
2.Chondroblastoma: Chondroblastoma is a benign cartilage tumor arising in the
epiphysis of skeletally immature individuals. More than 75% of
chondroblastomas occur in long bones [45]. The most common location is
epiphysis, with possible extension to metaphasis. Chondroblastoma may have a
genetic basis in structural anomalies involving chromosomes 5 and 8 [46].
Macroscopically, there are nodules of relatively mature cartilage surrounded by
highly cellular tissue. Giant cells are usually present in the tumor. The most
12
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common presenting symptom is mild localized pain, which refers to joint. The
most common age range affected is 10–25 years old. Males are more frequently
affected than females (nearly 2:1). Chondroblastoma comprises less than 1% of all
bone tumors and approximately 9% of benign bone tumors [47]. The
chondroblastoma is a geographic lytic lesion with sclerotic margins in most
lesions on radiography and CT scan. The lesion may contain chondroid matrix
calcifications. The lesions are eccentrically located within the epiphysis with
extension into metadiaphysis as they enlarge. There may be an associated cortical
expansion or thinning (Figure 13A–C). On MRI, the lesions are typically low
signal on T1 and inhomogeneously high signal on fluid sensitive sequences. The
inhomogeneity is related to the chondroid matrix, calcification, and fluid within
the lesion [48] (Figure 13D–F). Curettage and bone grafting is the surgical
treatment of choice. Radiofrequency ablation may be considered in small lesions.
3.Chondromyxoid fibroma: Chondromyxoid fibroma is a benign lobulated
cartilaginous tumor. Approximately 60% of chondromyxoid fibromas occur in
long bones, with the proximal tibia being the single most frequent site. Genetic
basis has been described in the literature in the form of clonal abnormalities of
Figure 11.
Enchondroma: Frontal radiograph of the distal femur (A) and proximal femur (B) in two different patients
reveal the characteristic rings and arcs pattern of chondroid mineralization (yellow arrows). The lateral
radiograph of the forearm (C) shows an expansile lytic lesion (white arrow) in the mid-diaphysis of radius. It
demonstrates a narrow zone of transition without any periosteal reaction or associated soft tissue swelling. A
frontal radiographic view of the proximal phalanx of the little finger (D) shows a well-defined eccentric
osteolytic lesion (white arrow). The frontal radiograph of the index finger (E) shows an expansile well-
circumscribed osteolytic lesion (white arrow) with a chondroid matrix. The black arrow points to a cortical
breach concerning a pathological fracture.
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chromosome 6 and pronounced expression of type II collagen, which is unique
compared with other cartilaginous lesions. Microscopically, the lesion is
lobular with stellate cells in the myxoid background. The most common
presenting symptom is mild chronic pain. The mean age of presentation is
23 years, with 50 percent of patients are in the second decade at presentation.
There is slight medial predominance. On radiography and CT, the lesions are
Figure 12.
Ollier’s disease: Frontal radiograph of the left hand (A) demonstrates multiple circumscribed lucent areas
(white arrows) in hand with a sharp zone of transition. Frontal radiograph of the right femur (B) shows
vertical streaks of lucencies (black arrows) extending from diaphysis towards epiphysis. Frontal radiograph of
the right tibia and fibula (C) reveals an expansile enchondroma in the proximal fibular metaphysis (white
arrows) and a not that much expansile enchondroma in the tibial metadiaphysis.
Figure 13.
Chondroblastoma: Frontal radiographic view of the left pelvis (A) shows a calcified mass of the left ischium and
pubic bones. Coronal bone window (B) and axial soft tissue window (C) images demonstrate an expansile
osteolytic lesion (white arrows) with a well-defined lobulated margin and chondroid matrix (black arrow).
Chondroblastoma demonstrates a hypointense T1 signal (white arrow; D) with a peripheral sclerotic rim.
Coronal (E) and axial (F) T2-weighted fat-saturated images reveal heterogeneous hyperintense T2 signal of the
mass (white arrows) with extensive peritumoral edema.
14
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geographic with sclerotic margins. The lesions typically occur in metaphysis or
diaphysis, which are oriented along the longitudinal axis of the bone.
Approximately 60% of lesions are eccentric, with evidence of lobulation and
thinning of the cortex (Figure 14A and B). Pseudotrabeculations within the
lesion give the appearance of septations [49]. There is an absence of periosteal
reaction without pathologic fracture. On MRI, the lesion is typically isointense
to skeletal muscle on T1-weighted images, and on fluid sensitive sequences,
the lesion is centrally hyperintense with a peripheral band of intermediate
signal. There is a peripheral nodular enhancement or diffuse postcontrast
enhancement [50] (Figure 14C–E). The lesions are typically treated with
marginal excision with curettage and bone grafting. The recurrence rate is
approximately 3–22% [51].
4.Osteochondroma: Osteochondroma is cartilage capped exostosis with
continuous cortex and marrow extending from the underlying bone.
Osteochondroma most commonly arises from metaphysis or metaphyseal
equivalents. Approximately 95% of them are located in extremities; the femur is
most commonly affected [52]. Microscopically, the inner layer is composed of
normal bone; the middle layer is composed of cartilage cap with superficial
clusters of chondrocytes, and the outer layer is composed of perichondrium,
which is continuous with the periosteum of the underlying bone. The most
common presenting symptom is a chronically present hard swelling. It may
present as mechanical pain from trauma or impingement. Vascular complications
include pseudoaneurysm formation and arterial or venous stenosis/thrombosis.
Increasing pain and/or mass enlargement following skeletal maturation suggest
degeneration to chondrosarcoma [53]. Osteochondromas could be sessile or
pedunculated. On radiography and CT scan, the pedunculated osteochondroma
Figure 14.
Chondromyxoid fibroma: Bone window (A) and soft tissue window (B) axial CT head images show a well-
defined lobulated lytic lesion (white arrows) involving the mastoid and petrous parts of the right temporal bone
and clivus. A note is made of the low attenuation value of the CMF lesion and absent calcifications. On the T2-
weighted image (C), the CMF lesion demonstrates a peripheral hypointense sclerotic rim with an intrinsic high
signal (white arrow). It shows a hypointense T1 signal (D) and shows thick peripheral enhancement (E). MR
features to support the diagnosis of the chondromyxoid fibroma (CMF).
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demonstrates a narrow stalk with cauliflower exostosis (Figure 15D), and the
sessile osteochondroma is broad-based (Figure 15A and C). If near the joint,
osteochondroma tends to project away from the joint line, growing along the
forces generated by the location of the tendons and ligaments. The pelvic
osteochondromas could become very large before discovery. Rib lesions may
present with pneumothorax. Endochondral calcification may be seen within the
cartilage cap and medullary bone as the rings and arcs, punctate or flocculant
calcification. The overlying cartilage cap is generally thinned, not evaluated by
radiograph. Degeneration of the lesion to chondrosarcoma is suggested by
osseous destruction, change in calcifications, or enlargement of the cartilage cap
as evidenced by distortion of the fat planes. On MRI, the cortex of the lesion is
contiguous with the underlying bone. The overlying hyaline cartilage cap has a
lobulated high signal on fluid-sensitive sequences covered by thin
perichondrium and demonstrates a low signal on T1 and T2 sequences [54]
(Figure 15E and F). Surgical resection of the osteochondroma is recommended
when the cartilage cap thickness is greater than 1 cm. In one study, the use of
2 cm as a cutoff for distinguishing benign osteochondromas from secondary
chondrosarcomas provided sensitivities, specificities, positive predictive values,
and negative predictive values of 100%, 98%, 96%, and 100%, respectively, for
MR imaging and 100%, 95%, 93%, and 100%, respectively, for CT [54].
Treatment is mostly watchful waiting. Resection of the osteochondroma is
recommended when there are mechanical complications such as bursa
formation, nerve irritation, or impingement. Resection of the entire
perichondrium is required to avoid recurrence. Chondrosarcoma is typically
treated by wide surgical resection.
Multiple hereditary exostoses, also known as diaphyseal aclasis, is an
autosomal dominant condition in which there are multiple sessile and
pedunculated osteochondromas. Approximately 90% of patients have a
positive family history of this condition [55]. There is a symmetric widening
of the metaphysis with the normal underlying bone. Sessile osteochondromas
Figure 15.
Osteochondroma: Axial CT bone algorithm image (A) of the mid thorax shows a focal bulge in the anterior
right rib (white arrow) with cortical continuity, a finding also appreciated on the longitudinal grayscale
ultrasound image (B). It represents a sessile osteochondroma, another example of which is C (white arrow).
Frontal radiograph of the left tibia (D) reveals a pedunculated osteochondroma (white arrow) noted in the
metaphyseal region, with the cortex of the parent bone (tibia in this case) contiguous with that of the lesion, and
the lesion is directed away from the joint. The T2-weighted fat-saturated coronal (E) and axial (F) images
reveal the T2 hyperintense cartilage cap (yellow arrows) of that osteochondral lesion (white arrows).
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are more common than pedunculated osteochondromas. There is an
approximately 3–5% incidence of degeneration to chondrosarcoma [56].
Radiography is the 1st line modality to evaluate for this condition. MRI can be
performed to evaluate the thickness of the cartilage cap and evaluate for
complications from the mass effect. If the lesion is superficial, ultrasound can
also be used to evaluate for thickness and irregularity of the cartilage cap.
Surgical resection is performed if there are complications from mass effect or
evidence of degeneration to chondrosarcoma.
Trevor disease, also known as dysplasia epiphysealis hemimelica, is an
extremely rare, nonhereditary disease in which the osteochondromas arise
from the epiphysis. It affects approximately one in 1 million population [57].
Only one epiphysis is involved in the localized type, although multiple
epiphyses are affected involving the entire extremity in generalized type.
There is the presence of an exostosis arising from the epiphysis on
radiography and CT scan (Figure 16A and B). Surgical excision of mass is
usually performed to preserve the joint.
5.Juxtacortical chondroma: Juxtacortical chondroma is a chondroid tumor
arising in the periosteal layer of tubular bones. It is a rare benign tumor
comprising less than 2% of chondromas [58]. The most common age range
affected is second through fourth decades. Although, it may occur in children.
Juxtacortical chondroma is a surface lesion arising from the metaphysis of the
tubular bone-producing chondroid matrix. The lesion is located in the proximal
humerus and femur in 70% of cases. On radiography, there is saucerization of
the cortex with sclerotic margins and matrix calcification (in 75% of cases)
(Figure 17A). There may be associated soft tissue mass. On MRI, the lesion is
lobulated with iso to hypointense T1 signal and hyperintense T2 signal with
heterogeneous predominantly peripheral enhancement (Figure 17B–E). The
tumor demonstrates slow local progression. Wide surgical excision is the most
appropriate treatment for lesions greater than 3 cm in size [59].
Fibro-osseous lesions:
1.Fibrous cortical defect: Fibrous cortical defect is the most common benign
bone lesion [60]. The most common location is usually metaphysis or
Figure 16.
Trevor disease: Frontal radiograph of the right shoulder demonstrates an osteochondroma arising from right
proximal humeral epiphysis, suggesting Trevor Disease (A). Sagittal bone window image of ankle demonstrates
an osteochondroma arising from Talus (B).
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metadiaphysis junction of the femur or tibia. On radiographs, the fibrous
cortical defects are eccentric cortically based lucent lesions with mineralized
rim (Figure 18A and B). There is no involvement of the underlying medullary
cavity. There is no periosteal reaction. The fibrous cortical defects are typically
hypointense on T1 weighted images and hyperintense on T2-weighted images
(Figure 18C and D). The signal intensity depends on the stage of healing.
Fibrous cortical defects are typically seen incidentally on radiographs. These
are no-touch lesions (no treatment is required). Benign fibro-osseous lesions
may be metabolically active on FDG PET CT exam and should not be confused
with metastases [61].
Figure 18.
Fibrous cortical defect: Frontal (A) and lateral (B) radiographs of distal femur demonstrate eccentric lucent
intracortical defect (white arrows) outlined by a rim of sclerosis. Note that there is no involvement of the
underlying medullary cavity, and there is no periosteal reaction. The lesion (white arrows) demonstrates a
hypointense T1 signal (C) and increased T2 signal with a peripheral hypointense sclerotic rim (D).
Figure 17.
Juxtacortical chondroma: Frontal radiograph of the left tibia and fibula (A) demonstrates a well-defined distal
tibial metadiaphyseal lucent lesion (white arrow) with underlying cortical saucerization or scalloping(yellow
arrows) and subjacent cortical sclerosis. It demonstrates a hypointense T1 signal (B) and an increased T2 signal
(C). T1-weighted fat-saturated pre (D) and postcontrast (E) images demonstrate peripheral enhancement of
the chondroma lesion (white arrow).
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2.Nonossifying fibroma: Nonossifying fibroma is a benign fibrous lesion
composed of spindle cells in a collagenous matrix. Nonossifying fibroma is
generally greater than 3 cm in greatest dimension (as opposed to a fibrous
cortical defect less than 3 cm in diameter) [62]. Nonossifying fibroma typically
originates in the metaphysis and is cortically based, most commonly found
around the knee and distal tibia. It can be multifocal in 8% of cases. Multifocal
nonossifying fibromas may be associated with neurofibromatosis (Jaffe-
Campanacci syndrome). Nonossifying fibroma is usually asymptomatic;
however, it could present with pathological fracture. It is typically seen in the
first and second decade of life.
Radiographic and CT appearance depends on the morphologic age of the
lesion. Initially, the lesion appears as a lytic, geographic area with a thin
sclerotic margin (Figure 19A and B). During early filling phases, it has a
thicker sclerotic margin forming peripheral bone. During late stages, the
lesion may be entirely sclerotic with usual remodeling to normal bone type
appearance. On MRI, the lesion is hypointense to skeletal muscle on T1 and
heterogeneous on fluid sensitive sequences with low signal areas and
hyperintense areas (Figure 19C and D). The regions of low signal areas are
fibrous elements and hemosiderin. There is peripheral and septal
enhancement following contrast administration. No cortical destruction or
soft tissue mass lesion is demonstrated. No treatment is required in a vast
majority of cases. If there is a risk for pathologic fracture due to the size of the
lesion, curettage and bone grafting can be performed. Syndromic form of
multiple nonossifying fibromas has a higher rate of recurrence after surgical
removal [63].
3.Fibrous Dysplasia: Fibrous dysplasia (FD) is a developmental disorder
characterized by the replacement of normal bone by immature bone and
cartilaginous tissue. Most cases are sporadic and are related to a mutation in
the GNAS1 gene. GNAS gene codes for the stimulatory alpha subunit of
guanine nucleotide-binding protein, and its mutation result in persistent
adenyl cyclase activation leading to osteoblastic proliferation. FD comprises
Figure 19.
Non-Ossifying Fibroma: Frontal and lateral radiographs of femur demonstrate an eccentric cortically based
radiolucent lesion with sclerotic margin in distal meta-diaphysis (A, B). On MRI of the same patient, the lesion
demonstrates predominantly hypointense signal on T1 and heterogenous signal on STIR due to fibrous elements
and hemosiderin (C, D).
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about 5–7% of all cases of benign tumors [64]. It can involve any bone and any
part of the bone.
Four clinical presentations of FD have been described [65]:
1.Monostotic FD (70–80% of all FD): Single bone is involved (Figure 20) with
craniofacial involvement in 10–27% of cases. It generally manifests at
10–30 years of age. FD lesions do not demonstrate an increase in size after
puberty.
2.Polyostotic FD (20–25%): Multiple bones are affected (Figure 21).
Craniofacial involvement is seen in 40–100% of cases. It usually manifests
before age 10. Polyostotic FD lesions, in some cases, increase in size even after
puberty.
3.McCune-Albright syndrome (3%): It is characterized by café-au-lait skin
macules, polyostotic fibrous dysplasia, and endocrine hyperfunction disorders
(precocious puberty, pituitary adenomas secreting growth hormone,
hyperthyroidism, and autonomous adrenal hyperplasia). Increased growth and
recurrence of the FD lesions are seen [66]. Some examples include the classic
“Shepherd’s crook” deformity of the femur, coxa vara, and scoliosis resulting
from spinal FD.
4.Mazabraud syndrome: It is characterized by the coexistence of polyostotic
fibrous dysplasia lesion and intramuscular myxomas.
Generally, FD lesions are lytic and well-defined but can look like almost any-
thing and are not associated with soft tissue swelling. The radiographical features of
FD can vary from ground-glass appearance, purely cystic (completely lucent)
lesions, mixed cystic and sclerotic lesions, to sclerotic lesions. They may demon-
strate a geographic (circumscribed) pattern with or without a sclerotic border or
appear as expanded lesions with or without associated endosteal scalloping. CT
accurately delineates margins of the FD lesions and helps in detecting subtle frac-
tures [67]. FD lesions demonstrate different CT patterns depending upon the
patient’s age, varying from homogeneous dense lesions in the pre-pubertal life to a
Figure 20.
Fibrous dysplasia: Left humerus radiograph (A) demonstrates an expansile diaphyseal lesion (white arrow)
with a ground-glass matrix. The lesion (white arrows) demonstrates hypointense T1 signal (B), heterogeneous
but predominantly increased T2 signal (C), and heterogeneous postcontrast enhancement (D).
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mixed lucent-dense pattern between ages of 10–20 years, and some of these lesions
may appear ground-glass in adult life. Diagnosing FD lesions purely by MRI is
highly challenging because of the highly variable signal demonstrated by these
lesions. Typically, the T1 signal is related to the ratio of fibrous tissue to the
mineralized matrix, with the FD lesions with high fibrous component showing an
intermediate T1 signal, compared to the low signal intensity of lesions with the
highly mineralized matrix. The metabolically active fibrous component appears
hyperintense on T2-weighted imaging and demonstrates intense enhancement
because of high vascularity [68]. Franz et al. described the “milk cloud appearance”
of the ground-glass FD lesions on contrast-enhanced T1-weighted MR imaging [69].
Active FD lesions demonstrate increased uptake on 18F-FDG PET/CT imaging
(18F-NaF is a bone-seeking positron-emitting radiopharmaceutical) which is cur-
rently the imaging modality of choice to evaluate FD activity [70].
In most cases, no treatment is required. Curettage and bone grafting is an option
if there is a risk for pathologic fracture due to the size of the FD lesion. Persistent
moderate-to-severe bone pain of FD can be controlled by intravenous
bisphosphonate therapy. However, it should be started only after ensuring the
normocalcemic status of the patient and dental evaluation (to decrease the risk of
osteonecrosis of the jaw) [71].
3.1 Histiocytic/Langerhans cell lesions
Langerhans cell histiocytosis (LCH)/Eosinophilic granuloma: Langerhans cell
histiocytosis is neoplastic proliferation of Langerhans cells/histiocytes in the
Figure 21.
McCune Albright syndrome: Radiographs (A–C) of the right humerus, left elbow and distal leg demonstrate
extensive polyostotic fibrous dysplasia (white arrows) with associated deformities. Axial CT head bone
algorithm image (D) demonstrates the characteristic ground-glass appearance of the cranium (yellow arrow)
and diffuse widening of diploic space. Axial T2-weighted MR image (E) reveals a heterogenous mixed pattern
of low and high SI within the expansile lesion. Also demonstrated is the heterogeneous T1 signal of the thickened
calvarium (yellow arrow) in fibrous dysplasia (F).
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reticuloendothelial system. These cells produce prostaglandins which are responsible
for medullary bone resorption. The incidence of LCH is approximately 1 in 200 000
children [72]. Flat bones are most commonly involved in approximately 65–70% of
cases. Skull is the most common site of involvement in flat bones. The monostotic
form is more common, seen in approximately 70% of cases [73]. The mean age at
diagnosis is typically 5–10 years. Classic radiographic/CT appearance includes solitary
or multiple punched-out skull lesions without sclerotic rim (Figure 22A). There is a
typical beveled edge appearance due to the asymmetrical involvement of inner and
outer tables. Spinal lesions may present with vertebra plana (complete collapse and
flattening of vertebral body) (Figure 22B). When present in long bones, the eosino-
philic granuloma is a permeative aggressive appearing lesion with possible associated
endosteal scalloping, periosteal reaction, and soft tissue mass (Figure 22C and D).
The lesion may present in any part of bone but most commonly affects diaphysis. On
MRI, these lesions are hypointense on T1, hyperintense on T2/STIR with diffuse post-
contrast enhancement (Figure 22E–G). Whole-body PET/CT can be utilized to eval-
uate polyostotic disease and monitor for response to therapy. LCH commonly
undergoes spontaneous resolution. If the symptoms persist, excision and curettage
are the treatment of choice.
3.2 Giant cell lesions
Giant cell tumor: Giant cell tumor (GCT) of bone, a benign but locally aggres-
sive tumor, comprises multinucleated giant cells interspersed with mononuclear
stromal cells. It comprises 20% of all benign bone tumors and 5% of all primary
bone tumors. GCT is more prevalent in females and between 20 and 30 years (80%
Figure 22.
Eosinophilic granuloma: Skull radiograph (A) demonstrates a punched-out lucent lesion (white arrow)
without a mineralized rim. Sagittal bone window image of the thoracic spine (B) reveals a collapsed vertebral
body, namely "vertebra plana" (black arrow). Frontal radiograph of left tibia (C) showing an expansile well-
defined osteolytic diaphyseal lesion (white arrow)with a benign periosteal reaction. Axial CT bone window
image (D) at the level of the diaphyseal lesion demonstrates a punched-out lucent lesion (white arrow). MR
images reveal intermediate T1 signal (E), heterogeneous increased T2 signal (F), and thick peripheral
enhancement (F).
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of cases occur between 20 and 50 years of age). It is rarely seen in the pediatric age
group (3% of cases occur before age 14). Though GCT mainly involves long bones,
any bone can be affected. The most common location of GCT is around the knee
(distal femur and proximal tibia), followed by the distal radius and sacrum [74].
Campanacci and Enneking’s clinic radiological staging of GCT: Stage I-The lesion
is restricted to the marrow, and bone contour is not affected (cortex may be thinned
out); Stage II- Cortical bulging without any signs of rupture; Stage III- Cortical
breach with an invasion of soft tissues [75].
Typical radiographic presentation of GCT is that of a circumscribed, eccentric,
epiphyseal lytic lesion that extends to the subchondral bone in patients with closed
physis. GCT demonstrates a “soap bubble” appearance on radiographs and CT
because of bony septae (Figure 23A and B). The MR features of GCT are
nonspecific. Most commonly, GCT shows hypointense T1 signal and heterogeneous
T2 signal (due to collagen content of fibrous components of GCT and deposition of
hemosiderin) [76] (Figure 23C–F). Contrast administration helps in delineating
solid and cystic components. On scintigraphy, there is increased Technetium 99 m–
methylene diphosphonate uptake along the periphery of the lesion with central
photopenia. An aggressive GCT may demonstrate expansile remodeling, cortical
thinning or destruction, a wide zone of transition, and associated soft tissue. Fluid–
fluid levels within GCT suggest secondary aneurysmal bone cyst (ABC) formation.
Though intralesional procedures (such as curettage and cement placement) are a
preferred approach to treat GCT, they are complicated by recurrence because of
residual tumor tissue. He et al. described marginal infiltration as the “paintbrush
borders” sign on MRI and advocated it as an independent prognostic factor for local
recurrence of GCTB after intralesional curettage [77]. In advanced GCT,
Denosumab is recommended for immediate local control and facilitates surgery
later [78].
Figure 23.
Giant cell tumor: Frontal radiograph of the left ankle (A) demonstrates a circumscribed lytic lesion (white
arrow) in the talus. Axial CT bone window image (B) better depicts the lobulated lytic lesion (white arrow)
with scalloped margins. The lytic lesion (white arrow) demonstrates a heterogeneous hyperintense T2 signal
(C). On the T1-weighted image (D), the lesion is isointense to muscle. Post-treatment MR images reveal dense
hypointense signal on both T1-weighted (E) and T2-weighted (F).
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Intraosseous hemangioma (IH) is a benign, slow-growing vascular neoplasm.
Though it mainly involves the vertebrae and craniofacial bones, it can rarely involve
long bones (mainly intramedullary in metadiaphyseal region; rarely cortical or
subperiosteal) [79]. IH are usually identified in females between the age of 30–
50 years. The most common pathologic type is cavernous hemangioma. On radio-
graphs, intraosseous hemangiomas may show a “sunburst” or “honeycomb”
appearance. On CT, IH may demonstrate the classic “polka dot” sign (due to
associated coarse appearance of the trabecular bone), honeycomb appearance of the
lytic lesion (because of internal linear trabeculations), or a spiculated “Irish lace”
pattern. MRI helps in better delineation of location and extent of the hemangioma.
On MRI, IH demonstrates intermediate to high T1 signal, high T2 signal, and diffuse
or peripheral enhancement with signal intensity similar to the adjacent vessels [80]
(Figure 24A and B). Most of the IH lesions are asymptomatic and need no treat-
ment. Symptomatic vertebral hemangiomas without neurologic deficits can be
managed by radiotherapy [81].
3.4 Tumor mimickers
1.Brodie Abscess: Brodie Abscess is an intraosseous abscess associated with
subacute pyogenic osteomyelitis and can often be confused as a bone tumor.
There is typically an insidious onset with systemic inflammatory signs, and
symptoms are often absent [82]. Staphylococcus aureus is the most common
organism involved. It typically occurs in the metaphysis of long bones, with
proximal and distal tibial metaphyses are most commonly involved. On
radiography/CT, Brodie abscess is typically a metaphyseal radiolucent lesion
with a sclerotic rim along the long axis of the bone (Figure 25A). If a lucent
Figure 24.
Intraosseous hemangioma: Sagittal MR images of lumbar spine reveal a focal well-circumscribed signal
abnormality in the vertebral body (white arrows) that is hyperintense on both T2-weighted (A) and
T1-weighted (B) images represent a small vertebral hemangioma.
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Figure 25.
Brodie Abscess: Frontal radiograph of the left knee (A) shows a lucent area (white arrow) with a faintly
sclerotic peripheral rim in the proximal tibial epi-metaphyseal region. B demonstrates the "Penumbra sign"
with rim lining of the abscess cavity (white arrow) with higher signal intensity than that of the remaining
abscess on T1-weighted imaging. The abscess shows increased T2 signal (white arrows; C-D) and peripheral
rim enhancement (white arrows) on the postcontrast images (E-F).
Figure 26.
Brown tumor: Frontal radiograph of the left knee (A) shows an eccentric, well-defined, lytic lesion (white
arrow) in the proximal tibial epi-metaphyseal region with associated thinning and expansion of cortex. Similar
appearing lytic areas (white arrows) are identified in the distal radius (B), pelvic bones and proximal right
femur (C), and distal radius and ulna and proximal fifth metacarpal (D). Color flow ultrasound image of the
neck (E) demonstrates a well-defined hypoechoic solid parathyroid mass (yellow arrow). The parathyroid mass
appears as a hot spot (yellow arrow) on nuclear imaging scan (F).
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tract extends to physis, diagnosis of Brodie abscess is strongly suggested. There
may be associated periosteal reaction. On MRI, there is a T1 hypointense
center with T1 hyperintense rim due to peripheral vascularized granulation
tissue lining the abscess cavity, which is also termed as “MR penumbra sign”
[83] (Figure 25B–E). There is typical rim enhancement following contrast
administration (Figure 25F). Brodie abscess is usually treated with surgical
curettage and antibiotic therapy [82].
2.Brown Tumor/Osteitis Fibrosa Cystica: Brown tumor, also known as osteitis
fibrosa cystica is the skeletal manifestation of hyperparathyroidism, most
commonly related to parathyroid adenoma. Parathormone induces osteoclastic
activity, which results in multifocal bone cyst formation and osteopenia. The
name brown tumor is derived from color resulting from hemosiderin
deposition. Brown tumor is rare, seen in less than 3% of cases of
hyperparathyroidism [84]. On radiography/CT, these lesions are typically
multifocal well-defined radiolucent lesions with expansion and thinning of the
overlying cortex (Figure 26A–D). SPECT or planar scintigraphy using Tc-
99 m sestamibi shows high radiotracer uptake in parathyroid adenoma
(Figure 26F). Fusion SPECT–CT can aid in further localization. Brown tumor
usually resolves after treatment of hyperparathyroidism in the form of surgical
resection of parathyroid adenoma or medical treatment depending on the
cause.
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